Ad
related to: csl behring log in
Search results
Results From The WOW.Com Content Network
CSL Behring is a biopharmaceutical company, manufacturing plasma-derived, and recombination therapeutic products. The company is a combination of Behringwerke, founded in 1904 in Marburg, Germany by Emil von Behring, and the Commonwealth Serum Laboratories (CSL), established in Australia in 1916 to provide vaccines to the people of Australia, as well as other companies acquired since 2004.
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines , antivenom , and cell culture reagents used in various medical and genetic research and ...
Etranacogene dezaparvovec, sold under the brand name Hemgenix is a gene therapy used for the treatment of hemophilia B. [4] [5] [6] Etranacogene dezaparvovec is an adeno-associated virus vector-based gene therapy which consists of a viral vector carrying a gene for clotting Factor IX. [6] The gene is expressed in the liver to produce Factor IX ...
An electronic lab notebook (also known as electronic laboratory notebook, or ELN) is a computer program designed to replace paper laboratory notebooks. Lab notebooks in general are used by scientists, engineers, and technicians to document research, experiments, and procedures performed in a laboratory. A lab notebook is often maintained to be ...
CSL Mobile Limited ( Chinese: 香港移動通訊有限公司; Cantonese Yale: Hēunggóng yìhduhng tūngseun yáuhhaahngūngsī) is a Hong Kong telecommunications company, which operates mobile network brands of " csl ", " 1O1O " and " Club SIM ". CSL is a subsidiary of Hong Kong Telecom (HKT) and was Hong Kong 's first mobile communications ...
Prothrombin complex concentrate ( PCC ), also known as factor IX complex, sold under the brand name Kcentra among others, is a combination medication made up of blood clotting factors II, IX, and X. [9] Some versions also contain factor VII. [10] It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Dade Behring was born from the merger of Behring Diagnostics and Deerfield, Illinois -based [1] Dade International, a private, independent company created by a group of investors led by Bain Capital [3] who had bought Baxter International 's diagnostics unit for over $440 million, in late 1994. The combined operations of the two companies ...
The gene therapy will compete with Australia-based CSL Behring’s Hemgenix, a similar treatment that won FDA approval for hemophilia B in 2022. That drug has a similar list price of $3.5 million ...
Ad
related to: csl behring log in